Absorption and Safety With Sustained Use of RELiZORB Evaluation (ASSURE) Study
Clinical trial NCT02750501 · COMPLETED
Trial details
- NCT number
- NCT02750501
- Sponsor
- Alcresta Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-20
- Primary completion
- 2017-03-30
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.